Sofinnova Investments’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Sofinnova Investments’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-104,700	Closed	-$122K	–	95
2024 Q2	$122K	Sell	104,700 -750,000	-88%	-$1.88M	0.01%	81
2024 Q1	$7.73M	Buy	854,700 +754,700	+755%	+$7.34M	0.43%	41
2023 Q4	$1.09M	Sell	100,000 -220,600	-69%	-$1.65M	0.06%	50
2023 Q3	$2.58M	Buy	320,600 +120,600	+60%	+$1M	0.16%	53
2023 Q2	$2.17M	Buy	+200,000	New	+$1.71M	0.14%	41
2020 Q4	–	Sell	-175,000	Closed	-$8.99M	–	83
2020 Q3	$8.99M	Buy	+175,000	New	+$1.51M	0.67%	26

Other funds holding MRNS

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments's MRNS Position: Q4 2024 in Review

Sofinnova Investments sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2024, closing a stake of 4,386,177 shares — an estimated $7.72M sold.

Sofinnova Investments first reported a position in MRNS in Q4 2020 and held it in 12 quarters. The position peaked at $19.3M in Q4 2023. 53 funds tracked by Wall St. Rank hold MRNS as of Q4 2024.

Sofinnova Investments reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2024 after selling out during the quarter.
Sofinnova Investments sold 4,386,177 Marinus Pharmaceuticals, Inc shares in Q4 2024, an estimated $7.72M.
Sofinnova Investments first reported a position in Marinus Pharmaceuticals, Inc in Q4 2020 and held it in 12 quarters.
Sofinnova Investments's Marinus Pharmaceuticals, Inc position peaked at $19.3M in Q4 2023.
53 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2024.

Based on Sofinnova Investments's 13F filing for Q4 2024, filed 14 Feb 2025.